Focusing on 'breakthroughs & controversies in mood, psychosis, schizophrenia, ADHD, and insomnia', the CINP 2019 Athens Meeting will highlight cutting edge pre-clinical, clinical or translational research, presented by recognized speakers and leaders in the field. Through the free and open exchange of ideas, CINP supports a strong focus on new approaches to the development and assessment of CNS pharmaceuticals by researchers working in both academia and industry. In addition to Keynote Lectures and Educational Symposia, the Meet the Expert Sessions, Workshops and the Young Investigator Forum will provide an excellent platform for audience participation and will be highly interactive.
|Extended abstract submission deadline||Closed|
|Extended early registration deadline||21 June 2019|
|Regular registration deadline||21 August 2019|
|Meeting dates||3 - 5 October 2019|